Balchem (BCPC) closed at $174.78 on Aug 4, 2026, up 0.7% on the day. The stock is up 4.7% over the past month, up 7.8% over three months, up 14.0% year to date and up 15.6% over the past year. It trades 5.0% below its 52-week high of $183.90 and 19.5% above its 52-week low of $146.28. The close sits above its 50-day moving average ($164.04) and above its 200-day moving average ($163.82).
BCPC is scheduled to report earnings on Oct 23, 2026, before market open.
BCPC options were pricing 26% at-the-money implied volatility on Oct 19, 2026, an IV rank of 62 over the past year.
Balchem is scheduled to report on Oct 23, 2026, before market open.
Yes — the Aug 4, 2026 close of $174.78 is 6.7% above the 200-day average of $163.82.
BCPC closed 5.0% below its 52-week high of $183.90.
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
